Letter to the editorMeige syndrome as a craniofacial type of dystonia treatable by dual dopaminergic modulation using L-DOPA/chlorpromazine: a case report
1Department of Neurology, Osaka Neurological Institute, 2-6-23, Osaka 561-0836, Japan 2Center for Drug Discovery and Development Sciences, Research Organization of Science and Technology, Ritsumeikan University, Kyoto 603-8577, Japan 3Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University, Tokushima 770-8503, Japan